Abstract
Background
The incidence of venous thromboembolism (VTE) among patients undergoing hepatic surgery is poorly defined, leading to varied use of VTE prophylaxis among surgeons. We sought to define the incidence of VTE after liver surgery and identify risk factors associated with VTE.
Methods
Incidence of VTE and associated risk factors within 90 days of hepatic resection between 2006 and 2012 at a major academic center was analyzed. Risk factors for VTE were identified using univariate and multivariate analyses.
Results
A total of 599 patients were included in the study cohort; 30 (5.0 %) had a prior history of VTE. The indications for surgery were malignant (90.8 %) and benign lesions (9.2 %). The majority of patients underwent a minor hepatectomy (<3 Couinaud segments; n = 402, 67.1 %) while 195 (32.6 %) patients underwent a major hepatectomy (≥3 Couinaud segments). Three hundred seven (51.3 %) patients were started on VTE chemoprophylaxis preoperatively with 407 (67.8 %) patients receiving VTE chemoprophylaxis within 24 h of surgery. Twenty-eight (4.7 %) patients developed VTE; 20 (3.3 %) had deep venous thrombosis (DVT), 11 (1.8 %) had pulmonary embolism (PE), and three (0.5 %) developed both DVT and PE. Among the VTE patients, 23 (82.1 %) had received VTE chemoprophylaxis. On multivariate analyses, history of VTE (odds ratio [OR] 4.51, 95 % confidence interval [CI] 1.81–17.22, P = 0.03), prolonged operative time (OR 1.17 per additional hour, 95 % CI 1.04–1.32, P = 0.009), and increased length of stay (LOS) (OR 1.07, 95 % CI 1.02–1.12, P = 0.01) were independent risk factors for VTE.
Conclusion
VTE within 90 days of hepatic resection is common, occurring in nearly one in 20 patients. Most VTE events occurred among patients who received current best practice prophylaxis for VTE. More aggressive strategies to identify and reduce the risk of VTE in patients at highest risk of VTE, including those with a history of VTE, extended operative time, and prolonged LOS, are warranted.
Similar content being viewed by others
References
Collins, R., A. Scrimgeour, S. Yusuf and R. Peto, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med, 1988. 318(18): p. 1162–73.
Mismetti, P., S. Laporte, J.Y. Darmon, et al., Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg, 2001. 88(7): p. 913–30.
Caprini, J.A., J.I. Arcelus, J.H. Hasty, et al., Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost, 1991. 17 Suppl 3: p. 304–12.
Gould, M.K., D.A. Garcia, S.M. Wren, et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): p. e227S–77S.
Dindo, D., N. Demartines and P.A. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004. 240(2): p. 205–13.
Mayo, S.C., A.D. Shore, H. Nathan, et al., Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford), 2011. 13(7): p. 473–82.
Ho, Y.H., F. Seow-Choen, A. Leong, et al., Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum, 1999. 42(2): p. 196–202; discussion 202–3.
De Martino, R.R., P.P. Goodney, E.L. Spangler, et al., Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg, 2012. 55(4): p. 1035–1040 e4.
Hyder, O., C. Pulitano, A. Firoozmand, et al., A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg, 2013. 216(6): p. 1049–56.
Sato, M., R. Tateishi, H. Yasunaga, et al., Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol, 2012. 47(10): p. 1125–33.
Bhayani, N.H., O. Hyder, W. Frederick, et al., Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery, 2012. 152(2): p. 218–26.
Jarnagin, W.R., M. Gonen, Y. Fong, et al., Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg, 2002. 236(4): p. 397–406; discussion 406–7.
Turley, R.S., S.K. Reddy, C.K. Shortell, et al., Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg, 2012. 16(9): p. 1705–14.
Reddy, S.K., R.S. Turley, A.S. Barbas, et al., Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg, 2011. 15(9): p. 1602–10.
Barton, J.S., G.M. Riha, J.A. Differding, et al., Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford), 2013.
Cerutti, E., C. Stratta, R. Romagnoli, et al., Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl, 2004. 10(2): p. 289–94.
Senzolo, M., M.T. Sartori and T. Lisman, Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford), 2009. 11(6): p. 459–64.
Salami, A., W. Qureshi, P. Kuriakose, et al. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. Transplant Proc, 2013. 45(1): p. 315–9.
Aldawood, A., Y. Arabi, A. Aljumah, et al., The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J, 2011. 9(1): p. 1.
Lesmana, C.R., S. Inggriani, L. Cahyadinata and L.A. Lesmana, Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int, 2010. 4(1): p. 433–8.
Dabbagh, O., A. Oza, S. Prakash, et al., Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest, 2010. 137(5): p. 1145–9.
Barclay, S.M., M.N. Jeffres, K. Nguyen and T. Nguyen, Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy, 2013. 33(4): p. 375–82.
Tzeng, C.W., M.H. Katz, J.B. Fleming, et al., Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford), 2012. 14(8): p. 506–13.
Merkow, R.P., K.Y. Bilimoria, M.D. McCarter, et al., Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg, 2011. 254(1): p. 131–7.
Morris-Stiff, G., A. White, D. Gomez, et al., Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford), 2008. 10(5): p. 311–4.
Hacker, R.I., G. Ritter, C. Nelson, et al., Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience. J Crit Care, 2012. 27(3): p. 250–4.
Cohen, A.T., M.B. Wagner and M.S. Mohamed, Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. Am J Surg, 1997. 174(1): p. 1–5.
McLeod, R.S., W.H. Geerts, K.W. Sniderman, et al., Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg, 2001. 233(3): p. 438–44.
De, A., P. Roy, V.K. Garg and N.K. Pandey, Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis, 2010. 21(1): p. 57–61.
Mita, K., H. Ito, R. Murabayashi, et al., Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents. Ann Surg Oncol, 2012. 19(12): p. 3745–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ejaz, A., Spolverato, G., Kim, Y. et al. Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy. J Gastrointest Surg 18, 1116–1124 (2014). https://doi.org/10.1007/s11605-013-2432-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-013-2432-x